A study of brain insulin receptors, AChE activity and oxidative stress in rat model of ICV STZ induced dementia.
In the present study, role of brain insulin receptors (IRs) in memory functions and its correlation with acetylcholinesterase (AChE) activity and oxidative stress in different brain regions were investigated in intracerebroventricular (ICV) streptozotocin (STZ) induced dementia model. Rats were treated with STZ (3 mg/kg, ICV) on day 1 and 3. Donepezil (5 mg/kg po) and melatonin (20 mg/kg ip) were administered in pre- and post-treatment schedules. Morris water maze test was done on day 14 and animals were sacrificed on day 21 from 1st STZ injection. Memory deficit was found in STZ group as indicated by no significant decrease in latency time antagonized by donepezil and melatonin. IR protein level was found significantly increased in trained group as compared to control, whereas STZ decreased IR level significantly as compared to trained rats in hippocampus which indicates that IR is associated with memory functions. STZ induced decrease in IR was reversed by melatonin but not by donepezil. Melatonin per se did not show any significant change in IR level as compared to control. AChE activity (DS and SS fraction) was found to be increased in hippocampus in STZ group as compared to trained which was inhibited by donepezil and melatonin. Increase in MDA level and decrease in GSH level were obtained in STZ group indicating oxidative stress, which was attenuated by donepezil and melatonin. Effectiveness of antioxidant, melatonin but not of anti-cholinesterase, donepezil against STZ induced changes in IR indicates that IR is more affected with oxidative stress than cholinergic changes.
Agrawal
Rahul
R
Division of Pharmacology, Central Drug Research Institute, Chatter Manzil Palace, M.G. Road, P.O. Box 173, Lucknow 226001, Uttar Pradesh, India.
Tyagi
Ethika
E
Shukla
Rakesh
R
Nath
Chandishwar
C
D000110:Acetylcholinesterase / Q000378:metabolism*; D000818:Animals; D000903:Antibiotics, Antineoplastic / Q000008:administration & dosage / Q000633:toxicity*; D015415:Biomarkers; D001786:Blood Glucose / Q000378:metabolism; D015153:Blotting, Western; D001835:Body Weight / Q000187:drug effects; D001923:Brain Chemistry / Q000502:physiology*; D002800:Cholinesterase Inhibitors / Q000494:pharmacology; D003704:Dementia / Q000139:chemically induced* / Q000201:enzymology / Q000378:metabolism*; D000077265:Donepezil; D004591:Electrophoresis, Polyacrylamide Gel; D005978:Glutathione / Q000378:metabolism; D007189:Indans / Q000494:pharmacology; D007276:Injections, Intraventricular; D008297:Male; D008315:Malondialdehyde / Q000378:metabolism; D018782:Maze Learning / Q000187:drug effects; D018384:Oxidative Stress / Q000187:drug effects*; D010880:Piperidines / Q000494:pharmacology; D051381:Rats; D017207:Rats, Sprague-Dawley; D011972:Receptor, Insulin / Q000187:drug effects / Q000378:metabolism*; D013311:Streptozocin / Q000008:administration & dosage / Q000633:toxicity*
D000903:Antibiotics, Antineoplastic; D015415:Biomarkers; D001786:Blood Glucose; D002800:Cholinesterase Inhibitors; D007189:Indans; D010880:Piperidines; D008315:Malondialdehyde; D013311:Streptozocin; D000077265:Donepezil; D011972:Receptor, Insulin; D000110:Acetylcholinesterase; D005978:Glutathione